Clinical research

Comparison of outcome after patent foramen ovale closure in older versus younger patients

EuroIntervention 2011;7:209-215. DOI: 10.4244/EIJV7I2A35

Justin Luermans
Justin G. Luermans1, MD, PhD; Werner Budts2, MD, PhD; Jurriën M. Ten Berg1, MD, PhD; Herbert W. Plokker1, MD, PhD; Maarten J. Suttorp1, MD, PhD; Martijn C. Post1*, MD, PhD
1. Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands; 2. Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium

Aims: Percutaneous patent foramen ovale (PFO) closure seems to be effective for secondary prevention of cryptogenic stroke in patients younger than 55 years of age. The e

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

patent foramen ovaletranscatheter closurecryptogenic thromboembolismelderly
Read next article
Clinical and procedural evaluation of the Nile Croco® dedicated stent for bifurcations: a single centre experience with the first 151 consecutive non-selected patients

Latest news